(Total Views: 414)
Posted On: 02/06/2024 2:17:17 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
I know LL is being tested in a GBM murine model and it makes sense that LL could be effective via inhibiting ccr5. Would anyone have input on this: am I missing something or would LL be potentially synergistic with something like NWBO's DC-Vax vaccine made to direct immune cells to the cancer antigens? In research updates it looks like DC-Vax is highly synergistic with PD-1 inhibitors (keytruda I think).
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)